Compare · CGC vs TLRY
CGC vs TLRY
Side-by-side comparison of Canopy Growth Corporation (CGC) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CGC is the larger of the two at $2.86B, about 4.0x TLRY ($715.4M).
- Over the past year, CGC is down 18.5% and TLRY is up 28.3% - TLRY leads by 46.8 points.
- TLRY has been more active in the news (13 items in the past 4 weeks vs 1 for CGC).
- CGC has more recent analyst coverage (19 ratings vs 14 for TLRY).
- Company
- Canopy Growth Corporation
- Tilray Brands Inc.
- Price
- $1.13+2.74%
- $6.21+0.98%
- Market cap
- $2.86B
- $715.4M
- 1M return
- +19.44%
- -4.02%
- 1Y return
- -18.48%
- +28.28%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- News (4w)
- 1
- 13
- Recent ratings
- 19
- 14
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest CGC
- 'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign
- SEC Form 4 filed by Yanofsky Theresa
- SEC Form 4 filed by Atkins M Shan
- SEC Form 4 filed by Bayern Joseph
- SEC Form 4 filed by Lazzarato David Angelo
- Canopy Growth Unveils New Brand 'Deelish': High THC, Everyday Price
- Canopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis Clinic
- Canaccord Genuity initiated coverage on Canopy Growth
- Canopy Growth Announces Storz & Bickel Executive Transition
- Canopy Growth Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Latest TLRY
- Manitoba Harvest Launches Superfood Smoothie Boosters, Exclusively at Sprouts Farmers Market Nationwide
- Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
- BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
- SEC Form 4 filed by Hopkinson David G.
- Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B7 filed by Tilray Brands Inc.
- Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
- SEC Form 424B5 filed by Tilray Brands Inc.
- Tilray Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership